Cargando…
Cysteine conjugate beta-lyase 2 (CCBL2) expression as a prognostic marker of survival in breast cancer patients
OBJECTIVE: Cysteine conjugate beta-lyase 2 (CCBL2), also known as kynurenine aminotransferase 3 (KAT3) or glutamine transaminase L (GTL), plays an essential role in transamination and cytochrome P450. Its correlation with some other cancers has been explored, but breast cancer (BC) not yet. METHODS:...
Autores principales: | Meng, Xiangyu, Wang, Ling, He, Miao, Yang, Zhaoying, Jiao, Yan, Hu, Yubo, Wang, Keren |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9246202/ https://www.ncbi.nlm.nih.gov/pubmed/35771747 http://dx.doi.org/10.1371/journal.pone.0269998 |
Ejemplares similares
-
Kynurenine aminotransferase 3/glutamine transaminase L/cysteine conjugate beta-lyase 2 is a major glutamine transaminase in the mouse kidney
por: Yang, Cihan, et al.
Publicado: (2016) -
Fluctuations in AKT and PTEN Activity Are Linked by the E3 Ubiquitin Ligase cCBL
por: Olazábal-Morán, Manuel, et al.
Publicado: (2021) -
Exercise-induced peptide TAG-23 protects cardiomyocytes from reperfusion injury through regulating PKG–cCbl interaction
por: Cheng, Zijie, et al.
Publicado: (2021) -
Wntless (Wls): A Prognostic Index for Progression and Patient Survival of Breast Cancer
por: Zheng, Dandan, et al.
Publicado: (2020) -
Rab22a is a novel prognostic marker for cell progression in breast cancer
por: He, Miao, et al.
Publicado: (2020)